Eagle Health Investments’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Hold |
330,830
| – | – | 2.72% | 17 |
|
|
2025
Q1 | $9.69M | Hold |
330,830
| – | – | 2.52% | 14 |
|
|
2024
Q4 | $10.9M | Hold |
330,830
| – | – | 2.67% | 13 |
|
|
2024
Q3 | $14.7M | Hold |
330,830
| – | – | 2.78% | 16 |
|
|
2024
Q2 | $14.3M | Hold |
330,830
| – | – | 2.5% | 18 |
|
|
2024
Q1 | $9.67M | Hold |
330,830
| – | – | 1.8% | 18 |
|
|
2023
Q4 | $7.37M | Buy |
330,830
+63,200
| +24% | +$1.41M | 1.5% | 17 |
|
|
2023
Q3 | $6.62M | Hold |
267,630
| – | – | 1.46% | 17 |
|
|
2023
Q2 | $7.58M | Hold |
267,630
| – | – | 1.42% | 22 |
|
|
2023
Q1 | $6.15M | Hold |
267,630
| – | – | 1.2% | 20 |
|
|
2022
Q4 | $7.52M | Sell |
267,630
-62,083
| -19% | -$1.74M | 1.73% | 16 |
|
|
2022
Q3 | $9.32M | Sell |
329,713
-246,700
| -43% | -$6.98M | 2.14% | 17 |
|
|
2022
Q2 | $12.8M | Buy |
576,413
+145,000
| +34% | +$3.21M | 2.98% | 17 |
|
|
2022
Q1 | $12.6M | Hold |
431,413
| – | – | 3.09% | 17 |
|
|
2021
Q4 | $14.2M | Buy |
431,413
+195,900
| +83% | +$6.44M | 3.46% | 16 |
|
|
2021
Q3 | $10.9M | Hold |
235,513
| – | – | 3.45% | 15 |
|
|
2021
Q2 | $13M | Sell |
235,513
-119,137
| -34% | -$6.57M | 4.45% | 11 |
|
|
2021
Q1 | $18.3M | Buy |
354,650
+284,950
| +409% | +$14.7M | 7.19% | 4 |
|
|
2020
Q4 | $3.02M | Buy |
+69,700
| New | +$3.02M | 1.93% | 18 |
|